Titre :
|
Prevalence of medication treatment for attention deficit-hyperactivity disorder among elementary school children in Johnston County, North Carolina. (2002)
|
Auteurs :
|
Andrew-S ROWLAND ;
Emichael BOHLIG ;
Ajack NAFTEL ;
Dale-P SANDLER ;
L.I.L. STALLONE ;
David-M UMBACH ;
Coda. Westat Inc. Durham. NC. USA ;
Epidemiology Branch. National Institute of Environmental Health Sciences. National Institutes of Health. Research Triangle Park. NC. USA
|
Type de document :
|
Article
|
Dans :
|
American journal of public health (vol. 92, n° 2, 2002)
|
Pagination :
|
231-234
|
Langues:
|
Anglais
|
Mots-clés :
|
Prévalence
;
Thérapeutique
;
Thérapeutique médicamenteuse
;
Chimiothérapie
;
Enfant
;
Homme
;
Enfant 6 9 ans
;
Médicament psychotrope
;
Epidémiologie
;
Etats Unis
;
Amérique
;
Amérique du Nord
|
Résumé :
|
[BDSP. Notice produite par INIST-CNRS nz5m3R0x. Diffusion soumise à autorisation]. Objectives. This study estimated the prevalence of medication treatment for attention deficit-hyperactivity disorder (ADHD) among elementary school children in a North Carolina county. Methods. Parents of 7333 children in grades 1 through 5 in 17 public elementary schools were asked whether their child had ever been given a diagnosis of ADHD by a psychologist or physician and whether their child was currently taking medication to treat ADHD. Parents of 6099 children (83%) responded. Results. By parental report, 607 children (10%) had been given an ADHD diagnosis and 434 (7%) were receivingADHD medication treatment, Seventy-one% of the diagnosed children were receiving medication. Treatment rates varied by sex, race/ethnicity, and grade. Conclusions. If treatment patterns observed in this study are representative, the public health impact of ADHD may be underestimated.
|